Senior Analyst Scott Power from the Morgans Healthcare team speaks with Jon Pilcher, Chief Executive Officer of Neuren Pharmaceuticals (ASX:NEU). Jon explains a number of key catalysts which are expected in 2021.

Under the microscope: Weekly Wrap Week Ending 15 January 2021

A series of podcasts that include interviews with executives from ASX-listed companies and updates on the healthcare sector.